Artivion Inc at Deutsche Bank Leveraged Finance Conference Transcript
Good morning, everyone, and for those joining us on the webcast. My name is Anna Yang. I work at the high-yield credit desk covering health care. And it's my pleasure to introduce our next company, Artivion. And I will turn it over to Ashley Lee, Executive President and CFO.
Thank you, Anna. So before I begin, I'd like to say that this does contain forward-looking statements.
So we rebranded the company back in January of this year. And you can see that our name now really clearly reflects our desire to be one of the leaders in the treatment of aortic disease. Our strategy is pretty simple. We have committed to deliver double-digit topline growth through 2024 while at the same time, expanding gross margins and increasing acceleration in cash flow generation. And we're going to do this by acquiring and developing technologies that meet our customers' most pressing needs, while at the same time, improving clinical outcomes and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
